Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127010392 | 12701039 | 2 | F | 20160815 | 20160826 | 20160831 | 20160909 | EXP | DE-JUBILANT GENERICS LIMITED-1056900 | JUBILANT | JOURNAL: PSYCHOPHARMAKOTHERAPIE?AUTHOR: KRUGER T, JOCKERS-SCHERUBL M, GROHMANN R, RUTHER E, DEGNER D?TITLE: DEVELOPMENT OF EPILEPTIC SEIZURES UNDER THERAPY WITH OLANZAPINE AND VENLAFAXINE ER WITH FATAL OUTCOME?VOLUME: 23(3) YEAR: 2016 PAGES: 125-128 | 76.00 | YR | F | Y | 0.00000 | 20160909 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127010392 | 12701039 | 1 | PS | OLANZAPINE. | OLANZAPINE | 1 | 200221 | ||||||||||||
| 127010392 | 12701039 | 2 | SS | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127010392 | 12701039 | 3 | C | DABIGATRAN | DABIGATRAN | 1 | 0 | ||||||||||||
| 127010392 | 12701039 | 4 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | 0 | ||||||||||||
| 127010392 | 12701039 | 5 | SS | LORAZEPAM. | LORAZEPAM | 1 | 0 | ||||||||||||
| 127010392 | 12701039 | 6 | SS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | 0 | ||||||||||||
| 127010392 | 12701039 | 7 | C | PANTOPRAZOLE SODIUM. | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 127010392 | 12701039 | 8 | C | OXYCODONE/NALOXONE | NALOXONE HYDROCHLORIDEOXYCODONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127010392 | 12701039 | 9 | C | FESOTERODINE | FESOTERODINE | 1 | 0 | ||||||||||||
| 127010392 | 12701039 | 10 | C | calcium | CALCIUM | 1 | 0 | ||||||||||||
| 127010392 | 12701039 | 11 | C | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | 0 | ||||||||||||
| 127010392 | 12701039 | 12 | C | CHOLECALCIFEROL | CHOLECALCIFEROL | 1 | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127010392 | 12701039 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127010392 | 12701039 | Circulatory collapse | |
| 127010392 | 12701039 | Epilepsy | |
| 127010392 | 12701039 | Haemorrhage | |
| 127010392 | 12701039 | Multiple fractures |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |